AsymBio Kicks Off Construction of Fengxian R&D Building to Establish a Full-Lifecycle, One-Stop Biologics Service Ecosystem

---
AsymBio Kicks Off Construction of Fengxian R&D Building to Establish a Full-Lifecycle, One-Stop Biologics Service Ecosystem
Vote:
0 0
Previous Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)
Next Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)

Related News

Duoning Headquarters in Fengxian Biotechnology Park with Centers for R&D and Technology Applications

Duoning Biotech Celebrates Ground Breaking for Its Global Headquarters

Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion

WuXi Biologics' 25th Drug Substance Facility Completes First GMP Production, Manufacturing Process Execution with Zero Deviations

WuXi Biologics (Shanghai) Co., Ltd. Removed from the U.S. Commerce Department's Unverified List

LOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and Obtains Approval for Use

menu
menu